Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
$534M |
| 2 |
Amazon
AMZN
|
$432M |
| 3 |
Abbott
ABT
|
$420M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$472M |
| 2 |
Bank of America
BAC
|
$426M |
| 3 |
TE Connectivity
TEL
|
$399M |
| 4 |
Atlassian
TEAM
|
$364M |
| 5 |
Goldman Sachs
GS
|
$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Industrials | 9.76% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Luminar Technologies
LAZR
$114M
| $321K | ﹤0.01% |
6,341
-7
| -0.1% | -$354 |
|
|
ACRE
2202
Ares Commercial Real Estate
ACRE
$282M
| $320K | ﹤0.01% |
30,894
-42
| -0.1% | -$435 |
|
|
CHUY
2203
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $319K | ﹤0.01% |
8,336
-19
| -0.2% | -$727 |
|
|
NVRO
2204
DELISTED
NEVRO CORP.
NVRO
| $319K | ﹤0.01% |
14,804
-28
| -0.2% | -$603 |
|
2205
ChargePoint
CHPT
$239M
| $319K | ﹤0.01% |
6,823
-7
| -0.1% | -$327 |
|
2206
Arcturus Therapeutics
ARCT
$485M
| $318K | ﹤0.01% |
10,097
-19
| -0.2% | -$599 |
|
2207
Pliant Therapeutics
PLRX
$114M
| $317K | ﹤0.01% |
17,525
-26
| -0.1% | -$471 |
|
|
VZIO
2208
DELISTED
VIZIO Holding Corp.
VZIO
| $317K | ﹤0.01% |
41,152
-36
| -0.1% | -$277 |
|
|
INN
2209
Summit Hotel Properties
INN
$614M
| $317K | ﹤0.01% |
47,096
-86
| -0.2% | -$578 |
|
2210
IMAX
IMAX
$1.6B
| $315K | ﹤0.01% |
20,968
| – | – |
|
2211
Argan
AGX
$2.92B
| $315K | ﹤0.01% |
6,723
-11
| -0.2% | -$515 |
|
2212
Opko Health
OPK
$1.07B
| $314K | ﹤0.01% |
208,449
-345
| -0.2% | -$519 |
|
2213
Enviri
NVRI
$948M
| $314K | ﹤0.01% |
34,825
-63
| -0.2% | -$567 |
|
2214
Community Trust Bancorp
CTBI
$1.06B
| $314K | ﹤0.01% |
7,143
-13
| -0.2% | -$571 |
|
2215
Simulations Plus
SLP
$279M
| $313K | ﹤0.01% |
6,995
-13
| -0.2% | -$582 |
|
2216
Wolverine World Wide
WWW
$2.59B
| $313K | ﹤0.01% |
35,232
-63
| -0.2% | -$560 |
|
2217
Aehr Test Systems
AEHR
$765M
| $313K | ﹤0.01% |
11,790
-17
| -0.1% | -$451 |
|
2218
Altice USA
ATUS
$1.05B
| $313K | ﹤0.01% |
96,097
+564
| +0.6% | +$1.84K |
|
2219
Ethan Allen Interiors
ETD
$772M
| $312K | ﹤0.01% |
9,782
-18
| -0.2% | -$575 |
|
2220
Lifestance Health
LFST
$2.09B
| $311K | ﹤0.01% |
39,665
-165
| -0.4% | -$1.29K |
|
2221
Gray Television
GTN
$625M
| $311K | ﹤0.01% |
34,742
-66
| -0.2% | -$591 |
|
2222
Credicorp
BAP
$20.7B
| $311K | ﹤0.01% |
2,079
| – | – |
|
2223
Editas Medicine
EDIT
$248M
| $309K | ﹤0.01% |
30,524
-65
| -0.2% | -$658 |
|
2224
Artivion
AORT
$2.05B
| $308K | ﹤0.01% |
17,239
-31
| -0.2% | -$554 |
|
2225
Aecom
ACM
$16.8B
| $306K | ﹤0.01% |
3,315
-110
| -3% | -$10.2K |
|